Lorlatinib and bevacizumab activity in ALK-rearranged lung cancers after lorlatinib progression Journal Article

   


Authors: Choudhury, N. J.; Young, R. J.; Sellitti, M.; Miller, A.; Drilon, A.
Article Title: Lorlatinib and bevacizumab activity in ALK-rearranged lung cancers after lorlatinib progression
Journal Title: JCO Precision Oncology
Volume: 4
ISSN: 2473-4284
Publisher: American Society of Clinical Oncology  
Date Published: 2020-11-02
Start Page: 1333
End Page: 1338
Language: English
DOI: 10.1200/po.20.00271
PROVIDER: scopus
PMCID: PMC7713518
PUBMED: 33283131
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85096865220&doi=10.1200%2fPO.20.00271&partnerID=40&md5=84dc60cb1e7b2c62654ae13e51311449
Notes: Review -- Export Date: 4 January 2021 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Robert J Young
    228 Young
  2. Alexander Edward Drilon
    632 Drilon
  3. Alexandra Miller
    74 Miller
  4. Noura Jehan Choudhury
    40 Choudhury
  5. Matthew Joseph Sellitti
    4 Sellitti
Related MSK Work